Amurubicin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amurubicin, covering 2020-05-19 to 2020-05-19. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer [Phase 2]